OneThree Biotech

One of the most challenging aspects of developing a new medicine is understanding how a drug interacts with proteins in the human body and what the results of these interactions will be (e.g. side effects or treatment of certain diseases). OneThree Biotech have developed an artificial intelligence-driven platform that combines over 25 different types of biological, chemical and clinical data to quickly and accurately identify new potential drugs and predict their mechanisms. To date, the platform has benchmarked over 90% accuracy and has led to the discovery of new potential treatments for rare cancers and the start of multiple clinical trials.